Cargando…
Reversible renal impairment induced by treatment with the angiotensin II receptor antagonist candesartan in a patient with bilateral renal artery stenosis
BACKGROUND: It is well established that ACE-inhibitors should be avoided in patients with renal artery stenosis. In recent years it has also been recommended that caution should be demonstrated when angiotensin II blockers are used in the same type of patients but the evidence is based only on few c...
Autores principales: | Johansen, Thomas Lund, Kjaer, Andreas |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC32190/ https://www.ncbi.nlm.nih.gov/pubmed/11388887 http://dx.doi.org/10.1186/1471-2369-2-1 |
Ejemplares similares
-
Repositioning of the Angiotensin II Receptor Antagonist Candesartan as an Anti-Inflammatory Agent With NLRP3 Inflammasome Inhibitory Activity
por: Lin, Wen-Yu, et al.
Publicado: (2022) -
Complete atherosclerotic occlusion of infra-renal aorta and bilateral renal artery stenosis
por: Srivastava, Shalabh, et al.
Publicado: (2011) -
Steroid-Responsive Nephrotic Syndrome and Bilateral Renal Artery Stenosis: A Possible Role for Angiotensin-Mediated Podocyte Injury
por: Bhardwaj, Rahul, et al.
Publicado: (2012) -
Bilateral renal artery stenosis and epidermal nevus syndrome in a child
por: Alsohim, Fahad, et al.
Publicado: (2011) -
Surgical revascularization of bilateral renal artery stenosis due to fibromuscular dysplasia
por: Phukan, Chandan, et al.
Publicado: (2017)